Moderna, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.9 | $3.2 | $6.8 | $19.3 | $18.5 |
| Operating income | -$3.1 | -$3.9 | -$4.2 | $9.4 | $13.3 |
| Net income | -$2.8 | -$3.6 | -$4.7 | $8.4 | $12.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$2.1 | -$4.1 | -$3.8 | $4.6 | $13.3 |
| Share repurchases | $<0.1 | $0.0 | $1.2 | $3.3 | $0.9 |
Shares outstanding 399.2M · Free float 81.3%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.